Tearsheet

Universal Health Services (UHS)


Market Price (12/18/2025): $224.89 | Market Cap: $14.2 Bil
Sector: Health Care | Industry: Health Care Facilities

Universal Health Services (UHS)


Market Price (12/18/2025): $224.89
Market Cap: $14.2 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.9%, FCF Yield is 7.4%
Key risks
UHS key risks include [1] a significant dependence on revenue from government healthcare programs, Show more.
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
 
2 Low stock price volatility
Vol 12M is 33%
 
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care, Diabetes Management, and Oncology Treatments.
 
0 Attractive yield
Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 11%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 6.9%, FCF Yield is 7.4%
1 Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 11%
2 Low stock price volatility
Vol 12M is 33%
3 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care, Diabetes Management, and Oncology Treatments.
4 Key risks
UHS key risks include [1] a significant dependence on revenue from government healthcare programs, Show more.

Valuation, Metrics & Events

UHS Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Universal Health Services (UHS) stock experienced significant movement between August 31, 2025, and December 18, 2025, driven by several key developments. While the exact 24.1% movement cannot be precisely attributed without a specific starting price for August 31, 2025, and an ending price for December 18, 2025, the available information highlights factors that would contribute to such a change. The stock traded around $222.64 on December 16, 2025, and reached a 52-week high of $246.33, with a 52-week low of $153.09. On November 20, 2025, the stock was trading around $229 per share, and it hit a 52-week high of $231.48 on November 21, 2025. The company's Q3 2025 earnings announcement in late October played a crucial role in its performance.

1. Strong Q3 2025 Financial Results and Increased Forecast: Universal Health Services announced impressive financial results for the third quarter of 2025 on October 27, 2025, significantly exceeding analyst expectations. The company's reported net income attributable to UHS increased to $373.0 million, or $5.86 per diluted share, up 44.1% from the same period in 2024. Net revenues also rose by 13.4% to $4.495 billion. This strong performance led management to increase its full-year 2025 operating results forecast. The midpoint of the 2025 adjusted EPS guidance was increased by 6% to $21.80 per diluted share.

2. Expanded Stock Repurchase Program: The company's Board of Directors authorized a $1.5 billion increase to its stock repurchase program, raising the total authorization to $1.759 billion. During Q3 2025, UHS repurchased 1.315 million shares at an approximate cost of $234.3 million. This move aimed to enhance shareholder value and demonstrated confidence in the company's financial stability.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
UHS Return-4%-5%9%9%18%25%60%
Peers Return49%54%-18%6%15%8%147%
S&P 500 Return16%27%-19%24%23%14%108%

Monthly Win Rates [3]
UHS Win Rate50%50%67%50%58%58% 
Peers Win Rate57%65%43%50%52%53% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
UHS Max Drawdown-53%-15%-32%-17%-0%-13% 
Peers Max Drawdown-52%-3%-43%-18%-14%-27% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: HCA, THC, CYH, ACHC, SEM. See UHS Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

Unique KeyEventUHSS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-45.3%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven82.9%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven492 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-54.2%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven118.3%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven399 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-24.4%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven32.2%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven113 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-52.7%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven111.4%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven214 days1,480 days

Compare to HCA, THC, DVA, SEM, CYH


In The Past

Universal Health Services's stock fell -45.3% during the 2022 Inflation Shock from a high on 8/3/2021. A -45.3% loss requires a 82.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Universal Health Services (UHS)

Better Bets than Universal Health Services (UHS)

Latest Trefis Analyses

Trade Ideas

Select past ideas related to UHS. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%
UHS_6302022_Dip_Buyer_FCFYield06302022UHSUniversal Health ServicesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
40.3%57.7%-12.6%
UHS_9302020_Dip_Buyer_FCFYield09302020UHSUniversal Health ServicesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
24.8%29.8%-1.5%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%
UHS_6302022_Dip_Buyer_FCFYield06302022UHSUniversal Health ServicesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
40.3%57.7%-12.6%
UHS_9302020_Dip_Buyer_FCFYield09302020UHSUniversal Health ServicesDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
24.8%29.8%-1.5%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Universal Health Services

Peers to compare with:

Financials

UHSHCATHCCYHACHCSEMMedian
NameUniversa.HCA Heal.Tenet He.Communit.Acadia H.Select M. 
Mkt Price224.90471.85195.023.2014.5315.01105.02
Mkt Cap14.2112.917.20.41.31.88.0
Rev LTM16,99372,69820,84612,6443,2665,36914,818
Op Inc LTM1,94911,0783,3471,0824442931,516
FCF LTM9507,2921,502143-347174562
FCF 3Y Avg7735,7041,678-74-252239506
CFO LTM1,94811,9352,4784933354081,221
CFO 3Y Avg1,64110,4512,5503253084651,053

Growth & Margins

UHSHCATHCCYHACHCSEMMedian
NameUniversa.HCA Heal.Tenet He.Communit.Acadia H.Select M. 
Rev Chg LTM10.2%6.4%-0.6%0.7%4.6%45.3%5.5%
Rev Chg 3Y Avg8.7%6.6%3.1%0.9%9.0%-0.6%4.8%
Rev Chg Q13.4%6.4%3.2%-0.1%4.4%7.2%5.4%
QoQ Delta Rev Chg LTM3.2%1.6%0.8%-0.0%1.1%1.7%1.3%
Op Mgn LTM11.5%15.2%16.1%8.6%13.6%5.5%12.5%
Op Mgn 3Y Avg9.8%15.0%13.8%7.3%16.2%4.3%11.8%
QoQ Delta Op Mgn LTM0.5%0.1%0.4%1.6%-1.0%0.2%0.3%
CFO/Rev LTM11.5%16.4%11.9%3.9%10.3%7.6%10.9%
CFO/Rev 3Y Avg10.5%15.4%12.3%2.6%10.2%10.5%10.5%
FCF/Rev LTM5.6%10.0%7.2%1.1%-10.6%3.2%4.4%
FCF/Rev 3Y Avg4.9%8.4%8.1%-0.6%-7.8%5.6%5.2%

Valuation

UHSHCATHCCYHACHCSEMMedian
NameUniversa.HCA Heal.Tenet He.Communit.Acadia H.Select M. 
Mkt Cap14.2112.917.20.41.31.88.0
P/S0.81.40.90.00.70.30.7
P/EBIT6.59.35.00.38.24.85.7
P/E9.417.113.21.320.914.113.6
P/CFO6.68.57.20.96.73.86.6
Total Yield11.1%6.5%7.6%76.6%4.8%9.7%8.6%
Dividend Yield0.4%0.7%0.0%0.0%0.0%2.6%0.2%
FCF Yield 3Y Avg6.1%6.4%13.5%-20.8%-7.6%8.5%6.2%
D/E0.40.50.726.21.11.80.9
Net D/E0.40.40.625.91.01.80.8

Returns

UHSHCATHCCYHACHCSEMMedian
NameUniversa.HCA Heal.Tenet He.Communit.Acadia H.Select M. 
1M Rtn-0.6%-1.0%1.4%6.3%-7.2%17.8%0.4%
3M Rtn20.1%18.3%6.3%8.5%-33.7%22.9%13.4%
6M Rtn31.6%25.6%16.4%-3.3%-32.5%1.6%9.0%
12M Rtn23.7%54.5%47.1%-0.3%-63.3%-20.1%11.7%
3Y Rtn68.0%102.3%340.2%-16.0%-82.8%16.3%42.2%
1M Excs Rtn-1.4%-1.7%0.6%5.6%-7.9%17.1%-0.4%
3M Excs Rtn18.3%16.5%1.1%2.5%-35.5%18.0%9.5%
6M Excs Rtn19.2%13.2%4.0%-15.7%-44.9%-10.8%-3.4%
12M Excs Rtn9.4%40.4%31.6%-18.9%-75.3%-32.7%-4.7%
3Y Excs Rtn9.2%31.2%272.6%-77.0%-150.9%-50.3%-20.5%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Acute Care Hospital Services8,0817,6477,1086,3376,165
Behavioral Health Care Services6,1915,7305,5045,2095,210
Non-segment revenue10    
Other 2330134
Total14,28213,39912,64211,55911,378


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity1,863,811
Short Interest: % Change Since 11152025-0.8%
Average Daily Volume720,671
Days-to-Cover Short Interest2.59
Basic Shares Quantity62,974,000
Short % of Basic Shares3.0%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/28/20252.5%3.1%14.0%
7/29/20255.1%6.3%17.1%
2/27/20253.3%-1.2%3.7%
10/25/2024-9.8%-9.1%-11.9%
7/25/202410.2%14.9%23.3%
2/27/2024-2.4%6.0%9.8%
10/26/20231.7%2.6%13.5%
7/26/2023-5.5%-6.9%-12.8%
...
SUMMARY STATS   
# Positive91012
# Negative986
Median Positive3.9%6.1%11.7%
Median Negative-5.5%-6.2%-12.3%
Max Positive13.1%21.3%34.1%
Max Negative-9.8%-13.6%-32.0%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251107202510-Q 9/30/2025
6302025808202510-Q 6/30/2025
3312025508202510-Q 3/31/2025
12312024226202510-K 12/31/2024
93020241108202410-Q 9/30/2024
6302024808202410-Q 6/30/2024
3312024508202410-Q 3/31/2024
12312023227202410-K 12/31/2023
93020231108202310-Q 9/30/2023
6302023808202310-Q 6/30/2023
3312023508202310-Q 3/31/2023
12312022227202310-K 12/31/2022
93020221108202210-Q 9/30/2022
6302022808202210-Q 6/30/2022
3312022506202210-Q 3/31/2022
12312021224202210-K 12/31/2021